STIMOGEN Trademark

Trademark Overview

On Friday, March 11, 2022, a trademark application was filed for STIMOGEN with the United States Patent and Trademark Office. The USPTO has given the STIMOGEN trademark a serial number of 97307413. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, March 28, 2024. This trademark is owned by IBSA INSTITUT BIOCHIMIQUE SA. The STIMOGEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of infertility, made with follicle stimulating hormone
stimogen

General Information

Serial Number97307413
Word MarkSTIMOGEN
Filing DateFriday, March 11, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, March 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of infertility, made with follicle stimulating hormone

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIBSA INSTITUT BIOCHIMIQUE SA
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressLugano (Pazzallo) 6912
CH
Party NameIBSA INSTITUT BIOCHIMIQUE SA
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressMASSAGNO 6900
CH

Trademark Events

Event DateEvent Description
Friday, March 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 28, 2024SOU EXTENSION 3 GRANTED
Thursday, March 28, 2024SOU EXTENSION 3 FILED
Thursday, March 28, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 15, 2024SOU EXTENSION 2 GRANTED
Monday, January 15, 2024SOU EXTENSION 2 FILED
Monday, January 15, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 8, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 8, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 8, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 5, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 5, 2023TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Wednesday, April 5, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, April 5, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 5, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 27, 2023SOU EXTENSION 1 GRANTED
Monday, March 27, 2023SOU EXTENSION 1 FILED
Monday, March 27, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 22, 2022ASSIGNED TO EXAMINER
Wednesday, March 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 15, 2022NEW APPLICATION ENTERED

Related Keywords

stimogen follicle stimulating hormone made infertility preparations treatment pharmaceutical